Impact Partnership Wealth’s AbbVie ABBV Stock Holding History

Impact Partnership Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$357K	Buy	1,640 +41	+3%	+$9.1K	0.04%	248
2025 Q4	$365K	Buy	1,599 +546	+52%	+$124K	0.05%	250
2025 Q3	$244K	Sell	1,053 -2,556	-71%	-$520K	0.04%	257
2025 Q2	$670K	Buy	+3,609	New	+$671K	0.12%	96
2025 Q1	–	Sell	-4,842	Closed	-$860K	–	260
2024 Q4	$860K	Sell	4,842 -754	-13%	-$139K	0.17%	66
2024 Q3	$1.11M	Sell	5,596 -72	-1%	-$13.4K	0.25%	45
2024 Q2	$972K	Buy	5,668 +4,982	+726%	+$825K	0.26%	49
2024 Q1	$125K	Sell	686 -5,126	-88%	-$883K	0.05%	229
2023 Q4	$901K	Buy	5,812 +1,365	+31%	+$199K	0.33%	35
2023 Q3	$663K	Buy	4,447 +301	+7%	+$44.2K	0.21%	52
2023 Q2	$559K	Buy	+4,146	New	+$608K	0.19%	61

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Impact Partnership Wealth's ABBV Position: Q1 2026 in Review

Impact Partnership Wealth increased its AbbVie (ABBV) stake by 2.6% in Q1 2026, buying an estimated $9.1K and bringing the position to 1,640 shares worth $357K. The position accounts for 0.04% of the portfolio, ranked #248.

Impact Partnership Wealth first reported a position in ABBV in Q2 2023 and has held it in 11 quarters since. The position peaked at $1.11M in Q3 2024. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Impact Partnership Wealth held 1,640 shares of AbbVie worth $357K as of Q1 2026.
Impact Partnership Wealth bought 41 AbbVie shares in Q1 2026, an estimated $9.1K.
AbbVie made up 0.04% of Impact Partnership Wealth's portfolio in Q1 2026, its #248 holding.
Impact Partnership Wealth first reported a position in AbbVie in Q2 2023 and has held it in 11 quarters since.
Impact Partnership Wealth's AbbVie position peaked at $1.11M in Q3 2024.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Impact Partnership Wealth's 13F filing for Q1 2026, filed 23 Apr 2026.